These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2306236)

  • 21. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
    Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; Vyas KP; Kari PH; MacDonald JS
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1225-35. PubMed ID: 1904494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of antiparkinson agent dopazinol by rat liver microsomes.
    Vyas KP; Kari PH; Ramjit HG; Pitzenberger SM; Hichens M
    Drug Metab Dispos; 1990; 18(6):1025-30. PubMed ID: 1981508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the metabolic inversion of the 6'chiral center of simvastatin.
    Vickers S; Duncan CA
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1508-15. PubMed ID: 1764101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: identification of metabolites by gas chromatography/mass spectrometry.
    Uchiyama N; Kagami Y; Saito Y; Abe S; Ohtawa M; Hata S
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):189-96. PubMed ID: 1814736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
    Nordin C; Dahl ML; Eriksson M; Sjöberg S
    Lancet; 1997 Jul; 350(9070):29-30. PubMed ID: 9217719
    [No Abstract]   [Full Text] [Related]  

  • 26. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.
    Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; MacDonald JS
    Eur Heart J; 1992 Jul; 13 Suppl B():2-6. PubMed ID: 1644096
    [No Abstract]   [Full Text] [Related]  

  • 28. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes.
    Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extended worldwide experience. HMG-CoA reductase inhibitors: lovastatin and simvastatin].
    Mantell G
    Therapie; 1992; 47(2):161-4. PubMed ID: 1412144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative metabolism in vitro of a novel carcinogenic polycyclic aromatic hydrocarbon, 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene, and its two regioisomeric B-ring fluoro analogues.
    Rinderle SJ; Black SD; Sharma PK; Witiak DT
    Cancer Res; 1992 Jun; 52(11):3035-42. PubMed ID: 1591719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics and practical applications of simvastatin.
    Mauro VF
    Clin Pharmacokinet; 1993 Mar; 24(3):195-202. PubMed ID: 8343198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.
    Krasovec M; Elsner P; Burg G
    Dermatology; 1993; 186(4):248-52. PubMed ID: 8513188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ; Gilbert JD; Hsieh JY; Matuszewski BK; Ramjit HG; Bayne WF
    Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
    Tornio A; Pasanen MK; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):104-8. PubMed ID: 15998357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective hydroxylation at the aliphatic carbons of 7,8- and 9,10-dihydrobenzo[a]pyrenes by rat liver microsomes.
    Chiu PL; Mushtaq M; Weems HB; Yang SK
    Biochem Biophys Res Commun; 1984 Oct; 124(1):114-20. PubMed ID: 6497875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
    Yamauchi S; Linscheer WG; Beach DH
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective metabolism of 9-methyl-, 9-hydroxymethyl- and 9,10-dimethylanthracenes: absolute configurations and optical purities of trans-dihydrodiol metabolites.
    Von Tungeln LS; Fu PP
    Carcinogenesis; 1986 Jul; 7(7):1135-41. PubMed ID: 3719909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.